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ABSTRACT: Lipid accumulation within the lumen of endolysosomal vesicles is observed in 
various pathologies including atherosclerosis, liver disease, neurological disorders, lysosomal 
storage disorders, and cancer. Current methods cannot measure lipid flux specifically within the 
lysosomal lumen of live cells. We developed an optical reporter, composed of a 
photoluminescent carbon nanotube of a single chirality, which responds to lipid accumulation via 
modulation of the nanotube’s optical bandgap. The engineered nanomaterial, composed of short-
single stranded DNA and a single nanotube chirality,  localizes exclusively to the lumen of 
endolysosomal organelles without adversely affecting cell viability or proliferation, or organelle 
morphology, integrity, or function. The emission wavelength of the reporter can be spatially 
resolved from within the endolysosomal lumen to generate quantitative maps of lipid content in 
live cells. Endolysosomal lipid accumulation in cell lines, an example of drug-induced 
phospholipidosis (DIPL), was observed for multiple drugs in macrophages, and measurements of 
patient-derived Niemann-Pick type C fibroblasts identified lipid accumulation and phenotypic 
reversal of this lysosomal storage disease. Single-cell measurements using the reporter discerned 
sub-cellular differences in equilibrium lipid content, illuminating significant intracellular 
heterogeneity among endolysosomal organelles of differentiating bone marrow-derived 
monocytes. Single-cell kinetics of lipoprotein-derived cholesterol accumulation within 
macrophages revealed rates that differed among cells by an order of magnitude. This carbon 
nanotube optical reporter of endolysosomal lipid content in live cells confers additional 
capabilities for drug development processes and the investigation of lipid-linked diseases.  
 
Endosomes and lysosomes are vacuolar organelles responsible for the breakdown of 
lipids, proteins, sugars, and other cellular materials.1 The failure to catabolize or export 
lysosomal contents can result in lysosomal storage disorders (LSDs), a family of approximately 
50 diseases characterized by the accumulation of undigested substrates, such as lipids and 
glycoproteins, within the endolysosomal lumen due to an inherited defect in a single protein.2,3 
Lipid accumulation in the endolysosomal lumen is observed in many LSDs as well as during 
atherosclerotic foam cell formation,4 the transition from steatosis to non-alcoholic 
steatohepatitis,5 in multiple neurological disorders,6 cancer,7 and drug-induced phospholipidosis 
(DIPL).8  The search for small molecule therapeutics against LSDs, as well as our understanding 
of the aforementioned diseases is hampered by the limited number of tools available to assay 
lipid content exclusively within the endolysosomal organelles of live cells.9  
Although multiple classes of sensors and imaging modalities exist to study lipids, current 
probes are limited in their capabilities. Stains such as LipidTox can detect the general 
accumulation of lipids within cells10 but are not organelle-specific. Fluorophore-conjugated and 
intrinsically fluorescent lipid analogs are used for analyzing lipid trafficking.10 Lipid analogs, 
synthesized by conjugation of a fluorophore to a modified lipid, allow the tracking of uptake and 
incorporation of lipids into the cell membrane.11,12 Lipid dynamics can be tracked in live cells 
using fluorescent proteins fused with lipid-binding domains, however the expressed domains can 
hamper the native function of the lipid.13 Environmentally-sensitive fluorophores were recently 
developed, which can respond to lipid order14 in cell membranes undergoing processes such as 
endosomal maturation,15 while another family of polarity-sensitive probes, can integrate into 
lysosomal membranes and detect changes in the overall polarity,16 The bulk of these 
technologies are useful for studying lipids present within a biological membrane, but, to the best 
of our knowledge, no existing probe specifically localizes to the lumen of endolysosomal 
organelles and reports on the lipid content of its immediate environment. 
To develop a biocompatible fluorescent reporter for lipids in the endolysosomal lumen, 
we investigated the physicochemical properties of single-walled carbon nanotubes (SWCNTs). 
Semiconducting SWCNTs emit highly photostable and narrow-bandwidth near-infrared 
photoluminescence,17 which is sensitive to local perturbations.18 The availability of multiple 
species with different emission properties can facilitate multiplexed imaging.19 The SWCNT 
emission energy responds to the solvent environment20 via solvatochromic energy shifts.21 This 
response has been used to detect conformational polymorphism22 of DNA and the nuclear 
environment in live cells,23 as well as microRNA,24 via shifts down to ≤1 nm. While the self-
assembly of lipid derivatives on carbon nanotubes was observed over 14 years ago,25 the optical 
response of fluorescent carbon nanotubes to fatty acids has been noted more recently.26 
Due to their applications in biological sensing and imaging applications,27 the 
biocompatibility of carbon nanotubes has been a subject of much investigation.28,29 A recent 
comprehensive review concluded that the biocompatibility of single-walled carbon nanotubes is 
dependent on how the nanomaterial sample is processed and functionalized.30 In particular, 
multi-walled carbon nanotubes and long single-walled carbon nanotubes or nanotube 
preparations containing impurities have documented toxic effects on live cells.31  
Here, we present a biocompatible carbon nanotube optical reporter of lipids within the 
endolysosomal lumen of live cells. Composed of a non-covalent complex consisting of an 
amphiphilic polymer and a single (n,m) species (chirality) of carbon nanotube, the reporter 
exhibits a solvatochromic shift of over 13 nm in response to biological lipids. In mammalian 
cells, the reporter remains within the endolysosomal pathway and localizes specifically to the 
lumen of endolysosomal organelles without adversely affecting organelle morphology, integrity, 
capacity to digest substrates, or cell viability or proliferation. Using near-infrared hyperspectral 
microscopy, we spatially resolved the solvatochromic response of the reporter to lipids in the 
endolysosomal lumen and obtained quantitative lipid maps of live cells with sub-cellular 
resolution. Emission from the reporter identified the lysosomal storage disease Niemann-Pick 
type C (NPC) in fibroblasts from an NPC patient. Furthermore, the reporter benchmarked 
treatment, exhibiting a distinct signal reversal upon administration of hydroxypropyl-β-
cyclodextrin, a drug that reverses the disease phenotype. Additionally, endolysosomal lipid 
accumulation was detected using spectroscopy alone, in a 96-well plate format compatible with 
high-throughput drug screening. Using the reporter, single-cell kinetic measurements in a 
macrophage model system for lysosomal lipid accumulation identified a sub-population of cells 
that was both significantly lipid deficient and slower to accumulate cholesterol in the lysosomal 
lumen. In the context of primary monocyte differentiation into macrophages, we discovered that, 
as the lipid content in the lumen increases, individual endolysosomal organelles within single 
cells accumulate lipids at different rates. Thus, our optical reporter enables quantitative imaging 
and high-throughput measurement of the lipid content in the endolysosomal lumen of live cells. 
RESULTS AND DISCUSSION 
Carbon nanotube optical response to lipids 
To develop a reporter of endolysosomal lipid content, we first identified a structurally-
defined DNA-carbon nanotube complex that responds optically to lipids. Carbon nanotubes were 
non-covalently functionalized with specific ssDNA oligonucleotides to facilitate separation using 
ion-exchange chromatography,32 resulting in suspensions of single-chirality DNA-nanotube 
complexes. The introduction of low density lipoprotein (LDL), a biochemical assembly 
composed of lipids and proteins,33 induced a decrease in emission wavelength (blue shift) that 
ranged from 0 to 13 nm (Figure S1). The largest solvatochromic response was observed from the 
(8,6) nanotube spectral band complexed with ss(GT)6, a short oligonucleotide which facilitates 
separation of the (8,6) species (Figure S2).32 The isolated ss(GT)6-(8,6) complex exhibited 
absorption bands at 730 nm and 1200 nm and a single photoluminescence emission peak at 1200 
nm (Figure 1a, S2-3). Previous work by our lab indicates that the mean length of ss(GT)6-(8,6) 
complexes following the preparation method used is 88.9 nm.34 We also recently experimentally 
identified ss(GT)6-(8,6) as a sequence-chirality pair that optimally maximized both the high 
dynamic range of optical modulation by a lipid-like surfactant (SDC) and the stability of the 
DNA-nanotube complex.35 
The ss(GT)6-(8,6) complex was characterized by measuring the optical response to 
several classes of biomolecules and water-soluble lipid analogs. Cholesterol-conjugated 
polyethylene glycol (PEG), a water-soluble analog of cholesterol, induced a ~ 10 nm decrease in 
the emission wavelength of the complex at both 2 and 24 hours, while saturating concentrations 
of bovine serum albumin (BSA), dsDNA from salmon testes, or carboxymethyl cellulose had no 
measurable effect (Figure S4). The nanotube emission responded rapidly to cholesterol-PEG at 2 
hours, but at equilibrium, two different classes of water-soluble lipid analogs elicited equivalent, 
large blue shifting responses (Figure S5). The optical response of the ss(GT)6-(8,6) complex was 
monotonic and linear over two orders of magnitude of cholesterol concentrations (Figure 1b). A 
similar response was observed for both ceramide (Figure S6) and low-density lipoprotein (LDL) 
(Figure S6), indicating the general sensitivity of ss(GT)6-(8,6) to both water-soluble lipid analogs 
and native lipids. 
To probe the underlying mechanism governing the response of the ss(GT)6-(8,6) 
complex, we examined the dependence of emission on the dielectric environment.20 Using near-
infrared hyperspectral microscopy,19 we obtained the emission spectrum from individual surface-
adsorbed ss(GT)6-(8,6) complexes in 7 different solvent environments (Table S1). The peak 
emission wavelength of the complexes ranged over 20 nm and exhibited a direct correlation with 
solvent dielectric constant (Figure 1c) with a Spearman correlation of 0.89, p<0.01. This result 
suggests that the ss(GT)6-(8,6) complex exhibits a distinct solvatochromic response. 
 
Figure 1. Optical response of carbon nanotube complexes to lipid environments. (a) Normalized absorption and 
emission spectra of ss(GT)6-carbon nanotube complexes purified to isolate the (8,6) species. (b) Emission peak 
wavelength of ss(GT)6-(8,6) nanotube complexes in solution as a function of cholesterol-PEG concentration. Error 
bars are standard error of the mean, obtained from 3 technical replicates performed for each concentration. (c) Mean 
emission wavelength of ss(GT)6-(8,6) nanotube complexes exposed to different solvents. Error bars are standard 
errors of the mean, obtained from 5 technical replicates for each solvent. (d) Frames from all-atom molecular 
dynamics simulations of equilibrated structures of the ss(GT)6-(8,6) nanotube complex in water, and the same 
complex equilibrated in the presence of cholesterol or sphingomyelin. (e) Water molecule density as a function of 
distance from the center of the equilibrated ss(GT)6-(8,6) nanotube complex and the same complex equilibrated in 
the presence of cholesterol or sphingomyelin. 
 
For further understanding how lipids interact with the surface of ss(GT)6-(8,6) nanotube 
complexes to induce a solvatochromic shift, we conducted all-atom replica exchange molecular 
dynamics simulations.36,37 First, ss(GT)6 oligonucleotides were equilibrated on the (8,6) 
nanotube (Figure S7) to obtain an equilibrium configuration that exhibited a tight association 
between the ssDNA and nanotube (Figure 1d). Cholesterol molecules were then added and 
equilibrium was reached after 100 ns (Figure S7). In the resulting configuration, cholesterol 
bound to exposed regions on the nanotube and induced rearrangement of DNA on the nanotube 
surface (Figure S8). The combined effect was an 18.7% decrease in the density of water 
molecules within 1.2 nm of the nanotube surface (Figure 1e). These simulations were repeated 
with sphingomyelin molecules and a similar reduction in water density was observed (Figure 1d-
e). The simulations suggest that lipid binding to the ss(GT)6-(8,6) complex reduces the water 
density on the nanotube surface, thereby lowering the effective local solvent dielectric. As 
experimentally observed, the lower dielectric environment corresponds to a blue shift of the 
nanotube emission wavelength (Figure 1c).  
We further characterized properties of the ss(GT)6-(8,6) optical response to cholesterol. 
The emission shift on cholesterol addition to surface-adsorbed complexes was rapid (under 2 
minutes, limited by the hyperspectral instrument acquisition time, Figure S9). Sodium 
deoxycholate, a surfactant and water-soluble cholesterol analog, was added and subsequently 
removed from the surface-adsorbed complexes, demonstrating that the wavelength shift on 
analyte binding is intrinsically reversible (Figure S9). Furthermore, in an acidic environment, the 
response of the nanotube complex to lipids was similar to that at a neutral pH (Figure S9).  
Overall, the characteristics of the ss(GT)6-(8,6) complex suggest that it can function as a 
reporter of endolysosomal lipid accumulation in live cells. When prepared via previously 
described methods34 suspensions of ss(GT)6-(8,6) consist of short (~90 nm), singly dispersed 
nanotubes that are relatively free of impurities, and non-covalently functionalized with 
biocompatible single stranded DNA. This minimizes the key parameters of SWCNT cellular 
toxicity,30 a topic that is assessed below. The sample length distribution lies between ultra-short 
(50 nm) and short (150 nm) nanotubes, which maximizes cellular uptake of fluorescent 
nanotubes while minimizing bundling within cells.38 The observed brightness of structurally-
sorted ss(GT)6-(8,6) is intrinsically higher than unsorted DNA-nanotube sensors, as on-resonance 
excitation at 730 nm efficiently excites every nanotube present. Additionally, this particular 
sequence-chirality pair is relatively stable, and retains its structural integrity under surfactant 
exchange.35 The structure, stability, and brightness of ss(GT)6-(8,6), combined with its sensitivity 
and specificity to lipids over other classes of biomolecules, suggests that it may be applied to 
live-cell measurements of lipid accumulation.  
Uptake and localization of DNA-SWCNTs to the endolysosomal lumen 
Although past work suggests that DNA-SWCNTs incubated with cells are taken up via 
energy dependent processes and localize to the endolysosomal lumen, this has not been assessed 
quantitatively or on a single-organelle level.39-41  We quantitatively assessed the interaction of 
ss(GT)6-(8,6) complexes with mammalian cells using near-IR and visible fluorescence 
microscopy. Macrophages were incubated in complete 10% FBS-supplemented cell culture 
media with 0.2 mg/L of ss(GT)6-(8,6) complexes at 37 °C for 30 minutes, before washing with 
fresh, complex-free media. For the conditions used in our experiments, this concentration 
corresponds to approximately 39 pM of ss(GT)6-(8,6).
34 The cells exhibited bright near-IR 
emission, indicating that nanotubes were strongly associated with the cells (Figure S10). We 
observed that a ss(GT)6-(8,6) concentration of 0.2 mg/L, pulsed for 30 minutes, were the minima 
that resulted in sufficient NIR emission from all cell lines used in this work. We also measured 
the uptake of the ss(GT)6-(8,6) complexes as a function of temperature, and quantified the 
nanotube emission intensity associated with cells. Incubation at 4 °C resulted in 10-fold lower 
intensity than incubation at 37 °C (Figure S11), indicating that the complexes had been 
internalized by the cells via an energy dependent process. These results are consistent with 
previous reports of the energy-dependent uptake of ssDNA-nanotube complexes42 via 
endocytosis.39,40 The nanotube emission, quantified from over 700 individual cells incubated 
with the complex at 37 °C, followed a normal distribution, suggesting a relatively homogeneous 
uptake of the ss(GT)6-(8,6) complexes by the cells (Figure S10). 
To determine the localization of ss(GT)6-(8,6) complexes following uptake, we 
conducted a series of imaging experiments in macrophages (RAW 264.7 cell line and bone-
marrow derived monocytes) and a human osteosarcoma cell line  (U2OS cells). The ss(GT)6 
oligonucleotide was covalently labeled with visible fluorophores (Cy3, Cy5, or Alexa-647) to 
prepare fluorophore-labeled ss(GT)6-nanotube complexes. Following internalization of 1 mg/L 
of the complexes by macrophages, we acquired emission from the Cy3 dye and NIR emission 
from the nanotubes in the same imaging field. This higher concentration of 1 mg/L was required 
to obtain sufficient emission; it was used for all experiments performed with the unsorted 
nanotube sample. The colocalization between the signals, observed on two different detectors, 
indicates that emission from a fluorophore conjugated to the ssDNA on the nanotube is a reliable 
indicator of nanotube location (Figure S12). Next, we colocalized the Cy5-DNA-SWCNT 
fluorescent complexes with Lysotracker Green, a fluorescent probe that accumulates in 
endolysosomal organelles (Figure 2a, S13). A quantitative analysis using an unbiased auto-
thresholding approach indicated significant colocalization between the Cy5 and Lysotracker 
Green emission (Pearson coefficient of 0.92 ± 0.036, Manders split colocalization coefficient of 
0.95 ± 0.018), suggesting that the nanotube signal was contained within endolysosomal 
organelles. Concomitantly, the NIR emission from the nanotubes localized to the same regions of 
the cell as the visible emission from Lysotracker, further supporting the endolysosomal 
localization of the nanotubes (Figure S14).  
 
Figure 2. Localization of DNA-SWCNT to endolysosomal organelles. (a) Representative fluorescence 
microscopy images of 1 mg/L Cy5-labeled DNA-SWCNT complexes (red) and Lysotracker (green) in live cells. 
Scale bar = 10 µm.  (b) Representative confocal images of TMR-dextran (green) and 1 mg/L Alexa-647-SWCNT 
(red) in U2OS-SRA cells. Lines (cyan) denote cross sections from the images extracted for further analysis in (c). 
Scale bar = 10 µm. (c) Intensity profiles of TMR (green) and Alexa 647 (red) fit with Gaussian functions. (d) 
Representative TEM images of AuNP-SWCNT complexes imaged on the TEM grid. Scale bar is 250 nm.  
(e) Representative TEM image of an AuNP-SWCNT complex within an endolysosomal organelle. Scale bar is 100 
nm. (f) Relative frequency histogram of AuNP-SWCNT complexes per endolysosomal organelle. (g) Relative 
frequency histograms comparing the experimentally observed and predicted numbers of AuNPs per endolysosomal 
organelle if AuNPs were not attached to SWCNT complexes.   
We next assessed the localization of the nanotubes within the lumen of individual 
endolysosomal organelles, by pulsing the cells with fluorescent (TMR) 10,000 MW dextran, a 
polymer that accumulates in the endolysosomal lumen and does not degrade.43 Following 
overnight incubation, the cells were maintained in dextran-free media for 3 hours, before 1 mg/L 
Alexa-647 labeled nanotube complexes were introduced to the cell media for 30 minutes and 
then washed away. One hour later we performed high magnification confocal microscopy in the 
live cells. An analysis of over 40 cells (Figure 2b, S15) indicates that 50% TMR dextran labeled 
endolysosomal organelles colocalized with Alexa 647-nanotube complexes, suggesting that 
within an hour following their addition, the nanotubes had been transported to the dextran-loaded 
endolysosomal organelles. We extracted line intensity profiles of TMR and Alexa 647 emission 
and fit them with Gaussian functions (Figure 2c, S15). The single Gaussian intensity 
distributions of both fluorophores overlapped significantly, with centers that colocalized with 
diffraction-limited resolution. This result suggests that the nanotubes localized to the same 
region of endolysosomal organelles as dextran, which is known to remain in the endolysosomal 
lumen.43 
To further confirm the presence of DNA-SWCNTs in the endolysosomal organelles, 
TEM analysis was performed. As single-walled carbon nanotubes, composed of only one layer 
of cylindrical graphene, do not have sufficient electron density to be visible by TEM in cells, we 
used gold-labeled DNA-nanotube complexes to perform the first incidence of gold-enhanced 
TEM imaging of individualized SWCNTs in mammalian cells. Citrate-capped gold nanoparticles 
(~ 10 nm diameter) were conjugated to thiolated ssDNA-nanotube complexes.44 Unbound gold 
nanoparticles were removed via centrifugation. Images of the gold nanoparticle-nanotube 
complexes (AuNP-SWCNT) deposited directly onto a TEM grid (Figure 2d, S16a) confirmed 
that all gold nanoparticles were attached to carbon nanotubes. We then incubated RAW 264.7 
macrophages with 1 mg/L of the gold-labeled nanotubes, and fixed the cells for TEM imaging 
after removing free gold-nanotube complexes from the solution. In the cells, the gold 
nanoparticles were clearly visible as dark circles within endolysosomal organelles (Figure 2e, 
S16b-c). We quantified the number of AuNP-SWCNTs within each endolysosomal organelle 
(Figure 2f). From the relative frequency distribution, we found the probability that an 
endolysosomal organelle had one gold nanoparticle was 0.14. If two gold nanoparticles were to 
independently localize into the same vesicle, we calculated that the probability would be 
approximately 0.02 (0.14 x 0.14 = 0.02). In contrast, the experimentally determined number of 
endolysosomal organelles with two AuNP was four times higher (Figure 2g), suggesting that if 
two AuNP were observed within one endolysosomal organelle, then the two nanoparticles were 
statistically likely to be linked to each other via a nanotube. This, combined with the removal of 
free gold nanoparticles via centrifugation and the TEM images showing that all visualized 
AuNPs were attached to SWCNTs, suggests that the AuNPs within endolysosomal organelles 
were part of AuNP-SWCNT complexes. 
To determine the long-term fate of the complexes, we acquired NIR movies of ss(GT)6-
(8,6) complexes within macrophages at 6, 24 and 48 hours after the initial 30 minute incubation 
(Supplementary Videos 1, 2, and 3). At each time point, emission from the complexes exhibited 
both passive diffusion and directed, linear movements consistent with the active translocation of 
lysosomes along microtubules,45 suggesting that the nanotube complexes remain within 
endolysosomal organelles. The emerging view, from our series of experiments, indicates the 
efficient uptake of DNA-nanotube complexes via endocytosis, rapid transport to the late 
endosomes and lysosomes, and stable localization to the lumen of endolysosomal organelles. 
Biocompatibility of DNA-SWCNT complexes in mammalian cells 
We conducted several experiments to assess the degree to which ss(GT)6-(8,6) perturbed 
cells and endolysosomal organelles in order to determine whether this may be a complication of 
its use as a live-cell sensor. Using an annexin V and propidium iodide assay, we found that, at its 
working concentration (0.2 mg/L), ss(GT)6-(8,6) did not affect cell viability or proliferation 
(Figure S17). To determine if DNA-SWCNT complexes altered the morphology of 
endolysosomal organelles, AuNP-SWCNT complexes were incubated with RAW 264.7 cells for 
30 minutes before fixing and preparing for TEM imaging 6 hours later (Figure 3a). Analysis of 
the size, diameter and aspect ratio of endolysosomal organelles from the TEM images show no 
statistical differences between control macrophages and macrophages incubated with 1 mg/L 
complexes (Figure 3b, S18). Endolysosomal organelles in which gold-nanotubes were explicitly 
detected also displayed similar morphology to controls (Figure 3c, S19). At this elevated 
concentration of complexes (1 mg/L), we also did not observe a change in endolysosomal 
membrane permeabilization (Figure S20).  
  Figure 3. Ultra structural analysis of endolysosomal organelles. (a) Representative TEM images of cells that 
were untreated or incubated with 1 mg/L of AuNP-SWCNT complexes. Endolysosomal organelles are shaded blue, 
scale bars are 2 µm. (b) A comparison of the mean aspect ratio (left) and area (right) of endolysosomal organelles. 
Error bars are standard deviation and mean values were compared with an unpaired t-test. (c) Histograms of the 
distribution of the aspect ratio, major axis, and area of endolysosomal organelles from control cells and 
endolysosomal organelles containing AuNP-SWCNT complexes.  
 
We next assessed whether DNA-SWCNTs perturbed the ability of endolysosomal 
organelles to maintain their pH gradient. This was done via a confocal imaging study using 
LysoTracker, a lysomotropic fluorescent probe that accumulates in acidic vesicles. Human bone 
osteosarcoma cells transfected with type A scavenger receptors (U2OS-SRA)46 were treated with 
1 mg/L (five times higher than the working concentration) fluorophore-labeled DNA-nanotube 
complexes (Alexa 647-SWCNT) and fixed and stained with LysoTracker. Using fluorescence 
confocal microscopy, we imaged both Lysotracker and Alexa 647-SWCNT emission from 
endolysosomal organelles (Figure 4a, S21). If DNA-SWCNTs prevented endolysosomal 
organelles from maintaining a pH gradient, we would expect endolysosomal organelles 
containing the DNA-SWCNTs to show decreased levels of LysoTracker signal. This was not the 
case as quantification of LysoTracker fluorescence from organelles both with and without DNA-
SWNCT showed no significant difference in LysoTracker intensity (Figure 4b-c, S21).    
  To ensure that we could ascertain meaningful results from a DNA-SWCNT based 
reporter, we also investigated the effect of DNA-SWCNTs on the ability of endolysosomal 
organelles to hydrolyze lipoprotein molecules. We treated U2OS-SRA cells with 1 mg/L of 
Alexa 647-SWCNT for 30 minutes before incubation in fresh media for two hours. To induce the 
rapid uptake of lipoproteins, we then introduced 50 µg/mL of Alexa 488-labeled acetylated LDL 
(Alexa 488-AcLDL) to the cell media. Epifluorescence images showed a stark decrease in 
AcLDL puncta in both control and nanotube-treated cells between zero and two hours of AcLDL 
addition (Figure 4d, S22). Quantification of AcLDL regions of interest (ROIs), normalized by 
cell area showed that there was no significant difference in the number of AcLDL ROIs per 100 
µm2 between cells treated with the nanotubes and the control cells at both 0 and 2 hours (Figure 
4e), suggesting that DNA-SWCNTs did not perturb the hydrolysis of lipoproteins. A lipid 
biochemical assay showed no significant differences in the cholesterol or total lipid content of 
cell fractions in control and nanotube-containing cells (Figure S23). LipidTox imaging and the 
expression of LDL receptor (LDLr), also suggested that DNA-SWCNT complexes did not 
significantly alter lipid processing in cells (Figure S24-25). 
The above results suggest that singly-dispersed DNA-SWCNTs that have been separated from 
large nanotube bundles and carbonaceous impurities via ultra-centrifugation did not adversely 
affect cell viability or proliferation, or organelle morphology, integrity, or capacity to digest 
lipoproteins. However, additional work using different cell types and culture conditions are 
warranted prior to widespread application of the reporter. Moreover, as electronic structure and 
chirality of a nanotube sample were not found to directly affect toxological impact,47 our 
conclusions on biocompatibility likely hold for other relatively short DNA-single walled carbon 
nanotube complexes composed of different DNA sequences and chiralities.  
 
Figure 4. Assessing the effects of DNA-SWCNT on endolysosomal function. (a) Representative confocal images 
of LysoTracker (green), Alexa 647-SWCNT (red) and a merged image of the two in U2OS-SRA cells Scale bar is 
10 µm. (b) Intensity profiles of the two fluorophores along the dashed line (cyan) in the merged image. (c) Mean 
intensity of LysoTracker in endolysosomal organelles that contain Alexa 647-SWCNT emission and those that did 
not. Error bars are standard deviation. Mean intensity was compared with an unpaired t-test (n=9 images per 
channel).  (d) Representative epifluorescence images of Alexa 488-AcLDL (green) in U2OS-SRA cells, at 0 and 2 
hours after the addition of acetylated LDL, or in control cells. Scale bars are 10 µm. (e) Number of AcLDL ROIs per 
100 µm2. Error bars are standard deviation, obtained from 10 images per condition. Data were compared using a one 
way ANOVA with Tukey’s multiple comparison test. 
 
Detecting lipid accumulation in the endolysosomal lumen of live cells 
We investigated whether the ability of ss(GT)6 –(8,6) to detect lipids in vitro could be 
translated to the endolysosomal organelles of live cells (Figure 5a). RAW 264.7 macrophages 
were incubated with the complexes for 30 minutes in complete 10% serum-supplemented media 
at 37° C and washed with fresh media. To induce lysosomal accumulation of free cholesterol, we 
prepared cells that were pre-treated with U18666A,48 a compound that inhibits the action of 
NPC1,49 a membrane protein that effluxes free cholesterol out of the lysosomes (Figure 5a), to 
mimic the Niemann-Pick C1 disease phenotype. Cells were also pre-treated with Lalistat 3a2,50 
an inhibitor of lysosomal acid lipase (LAL), which is the central enzyme that hydrolyzes low 
density lipoproteins (Figure 5a).51 Inhibition of LAL leads to the accumulation of esterified 
cholesterol, which is observed in Wolman’s disease. 
Using near-IR hyperspectral microscopy, we acquired the emission from the complexes 
localized within the endolysosomal organelles of macrophages under these three conditions 
(Figure 5a). When the emission wavelength is mapped to a color-scale and overlaid on a 
transmitted light image, the spatially-resolved emission from ss(GT)6-(8,6) complexes resulted in 
live-cell maps of endolysosomal lipid content (Figure 5b). The mean emission blue-shift for the 
two drug-treated conditions was over 11 nm compared with the control, with a single population 
for all three conditions, indicating lipid accumulation in all endolysosomal organelles that 
contained the complexes (Figure 5c, S26). Neither Lalistat 3a2 nor U18666A directly perturbed 
the emission wavelength of the complexes (Figure S27). The endolysosomal lipid maps thus 
reflect the optical response of the complexes to the accumulation of lipids within the 
endolysosomal lumen. We quantified the nanotube emission response as a function of loading 
concentration. At a 5-fold dilution of the working concentration, the response of the emission 
wavelength to U18666A-induced lipid accumulation did not change, indicating that the emission 
spectra (Figure S28-29) and wavelength distribution of the ss(GT)6-(8,6) complex (Figure S28-
29) was consistent over a range of concentrations (Figure S28-29). Finally, we induced 
endolysosomal lipid accumulation in mouse embryonic fibroblasts (MEF) using U18666A, and 
detected a blue-shift in the ss(GT)6-(8,6) emission when compared with untreated controls 
(Figure S30). 
Based on the findings from our experiments, we present a model for the optical response 
of ss(GT)6-(8,6) ssDNA-nanotube complexes in live cells under the conditions investigated. The 
complexes enter the endolysosomal pathway and localize within the lumen of endolysosomal 
organelles. In the complex environment of the endolysosomal lumen, the nanotube emission 
functions as a cell-specific spectral fingerprint for the lipid content. Upon dysfunction of the 
NPC1 protein via introduction of U18666A to cells, free cholesterol (FC) accumulates within the 
lumen of endolysosomal organelles and adsorbs to the surface of the ss(GT)6-(8,6) complex, 
resulting in a distinct blue-shifting response of the nanotube emission. Similarly, upon 
introduction of Lalistat to cells, cholesteryl esters (CE) accumulate in the endolysosomal lumen, 
resulting in the adsorption of CE to the nanotube surface, and a concomitant blue-shifting 
response. In both situations, multiple secondary lipids also accumulate in the lysosomal lumen.52 
Hence, we find that the ss(GT)6-(8,6) DNA-nanotube complex functions as a quantitative optical 
reporter of lipid accumulation in the endolysosomal lumen via solvatochromic shifting of 
intrinsic carbon nanotube photoluminescence. Henceforth, we refer to ss(GT)6-(8,6) as the 
‘reporter’. 
As the nanotube emission is exclusively from the endolysosomal lumen, we investigated 
whether the nanotube spectra alone, obtained without imaging, could function as an analytical 
tool to benchmark drug-induced endolysosomal lipid accumulation in a high-throughput format. 
Using a customized NIR spectrometer,53 we obtained spectra from complexes within live RAW 
264.7 macrophages (Figure 5d) and detected a 9 nm shift in the emission from cells treated with 
U18666A –an example of a cationic amphiphilic drug that induces DIPL54 (Figure 5e). These 
results were similar to the hyperspectral data of control and U18666A-treated macrophages 
(Figure 5f), indicating the amenability of the complexes for both imaging and a spectroscopy-
based assay which facilitates higher throughput.  
 
Figure 5. Detection of endolysosomal lipid accumulation in live cells. (a) Schematics of the ss(GT)6-(8,6) 
nanotube complexes in macrophages treated with U18666A or Lalistat. (b) Overlay of transmitted light with 
hyperspectral image of RAW 264.7 macrophages incubated with ss(GT)6-(8,6) complex under the specified 
treatments. Color legend maps to nanotube emission peak wavelength. Scale bar = 50 µm. (c) Histogram of emission 
wavelengths of all pixels from the hyperspectral images, bin size of 1 nm. (d) Schematic of the optical setup for 
high-throughput measurements of ss(GT)6-(8,6) emission in live cells. (e) Spectra of ss(GT)6-(8,6) emission from 
live RAW 264.7 cells incubated in normal media (control), and in media with U18666A. (f) Mean center 
wavelengths of ss(GT)6-(8,6) emission from n = 5 technical replicates, acquired using hyperspectral imaging (I) and 
spectroscopy (S). Mean values were compared using a one way ANOVA with Sidak’s multiple comparison test. 
Error bars are standard error of the mean. ***=p<.001, ****=p<.0001. 
 
Measurement of lysosomal storage disorder phenotype in NPC1 patient-derived 
fibroblasts.  
The reporter was assessed for its response in primary cells from a patient with Niemann-
Pick type C1 (NPC1), a lysosomal storage disease characterized by an accumulation of 
unesterified cholesterol in the lysosomes.55,56 Fibroblasts from an NPC patient, as well as wild-
type (WT) human fibroblasts, were incubated with the reporter for 30 minutes, then rinsed, and 
incubated in fresh media. Hyperspectral data collected after 24 hours indicates that the reporter 
blue-shifted by an average of 6 nm in NPC1 human fibroblasts, compared to WT human 
fibroblasts (Figure 6a). The lipid content of WT fibroblast endolysosomal organelles was 
relatively homogeneous, as evinced by the narrow distribution of the reporter emission (Figure 
6b). In contrast, the reporter exhibited a broad emission profile within NPC1 cells (Figure 6b), 
confirming the published findings that NPC1 cells exhibit a wide distribution of lipid 
concentrations.57 The histogram also suggests that a sizeable fraction of endolysosomal 
organelles contain near-normal cholesterol content. 
To test the reversibility of the reporter in live cells, we measured the emission from the 
reporter in NPC1 fibroblasts treated with hydroxypropyl-β-cyclodextrin (HPβCD), a drug known 
to facilitate the efflux of accumulated cholesterol from the lumen of endolysosomal organelles.58 
After treatment with 100 µM HPβCD for 24 hours, hyperspectral imaging revealed significant 
red-shifting of the reporter emission from the same NPC1 cells that were previously blue-shifted 
(Figure 6a-b, S31). The distribution of reporter emission from the HPβCD-treated NPC1 
fibroblasts appeared notably similar to the emission from WT fibroblasts (Figure 6b, S31), and 
reduction of total cell cholesterol content was confirmed by fixing the cells and staining with 
filipin (Figure 6c). Filipin staining was more pronounced in NPC1 fibroblasts as compared to 
WT fibroblasts, and HPβCD treatment resulted in significantly diminished filipin signal in NPC1 
cells (Figure 6c, S32), thus validating the results obtained from the reporter alone. Additionally, 
pre-treatment of NPC1 fibroblasts with HPβCD prevented the blue-shifting of the reporter 
(Figure S33).  
 
Figure 6. Measurement of endolysosomal lipid accumulation and reversal in NPC1 patient-derived 
fibroblasts. (a) Mean reporter emission from wild-type fibroblasts, patient-derived NPC1 fibroblasts, and NPC1 
fibroblasts treated with hydroxypropyl-β-cyclodextrin (HPβCD) for 24 hours. Statistical significance was 
determined with a one-way ANOVA with Sidak’s multiple comparison test. (b) Histograms of the nanotube 
emission wavelength from single endolysosomal organelles of wild-type fibroblasts, NPC1 patient fibroblasts, and 
NPC1 fibroblasts treated with HPβCD for 24 hours. (c) Mean filipin intensity from WT fibroblasts, NPC1 cells, and 
NPC1 cells treated with HPβCD for 24 hours, at 48 hours after nanotube addition. Statistical significance was 
determined with a one-way ANOVA with Tukey’s multiple comparison test. All error bars are S.E.M. from 3 
technical replicate experiments. * = p<0.05, ** = p<0.01, *** = p<0.001. 
 
Single-cell kinetic measurements of lipid accumulation 
Recent technological advances have lead to an appreciation of the complexity of cell 
populations and the heterogeneity of single cells within a population of cells that seems uniform 
on a macroscopic level.59 The ability of the developed reporter to function in live cell imaging 
applications positions it to provide data on a single cell level. Such data would have the potential 
to identify previously unknown sub-populations of cells that could be crucial towards increasing 
our understanding of cellular lipid processing.  
We assessed whether the reporter could measure single-cell kinetics of endolysosomal 
lipid accumulation. RAW 264.7 macrophages were cultured in media with lipoprotein depleted 
serum (LPDS). Under these conditions the reporter emission wavelength was approximately 
1200 nm. Next, both AcLDL and U18666A were added to the cell media to induce 
endolysosomal lipid accumulation. Endolysosomal lipid accumulation was monitored via the 
acquisition of hyperspectral images every 10 minutes for 2 hours (Figure 7a). Single-cell 
emission trajectories were computed for all cells with reporter peak emission intensities of over 4 
times higher than the background. The mean reporter emission from individual cells blue-shifted 
and reached equilibrium over approximately 90 minutes (Figure 7b). For each cell, the spectral 
trajectories were fit with a single exponential function to obtain the time constant, time lag, and 
the starting and final reporter wavelengths (Figure S34). The time constants of lipid 
accumulation in the cells averaged approximately 40 minutes and followed a lognormal 
distribution (Figure 7c). One potential explanation for this finding is that a lognormal distribution 
is often observed for a quantity arising from multiple serial processes.60 We believe that this 
distribution of time constants from individual cells is consistent with the process of 
endolysosomal lipid accumulation, which involves sequential processes including LDL uptake 
into the early endosome, delivery of LDL to the lysosome, hydrolysis of esterified cholesterol by 
LAL, and the inhibited efflux of free cholesterol by NPC1.  
Interestingly, the distribution of time constants showed marked heterogeneity, with the 
slowest and fastest time constants differing by an order of magnitude. Cells exhibiting slower 
rates of lipid accumulation also exhibited an initial state of relative lipid deficiency. The time 
constant of lipid accumulation modestly correlated with the starting wavelength (Spearman 
correlation of 0.33, p<0.01). Notably, the slowest shifting cells (defined as cells with a time 
constant > 90 minutes) exhibited an initial average emission wavelength >1202 nm, 2 nm more 
red-shifted than the faster shifting cells (Figure 7d). This result suggests the existence of a 
subpopulation of cells that maintained both lipid-deficient endolysosomal organelles and an 
extremely slow rate of lipid accumulation; i.e. these individual cells in the population may be 
especially resistant to endolysosomal lipid accumulation. 
 
 Figure 7. Single-cell kinetics of lipid accumulation. (a) Overlaid brightfield and hyperspectral images of the 
reporter emission in RAW 264.7 macrophages upon addition of AcLDL (100 µg/mL) and U18666A (3 µg/mL) to 
LPDS media at t = 0, 30 minutes, and 60 minutes. Scale bar = 50 µm. (b) Single-cell trajectories of lysosomal lipid 
accumulation from 60 cells. Black curve is the mean. Error bars are standard deviation from n = 4 technical 
replicates. (c) Distribution of time constants of lipid accumulation in single cells fitted to a log-normal distribution. 
Bin size = 20 nm. (d) Scatter plot of the time constants vs. starting emission wavelength, n = 60 cells. Data from 4 
independent experiments were combined for this analysis. 
 
Quantifying intracellular heterogeneity in monocyte endolysosomal organelles.  
After demonstrating the reporter’s ability to quantify lipid accumulation on a single cell 
level, we investigated whether the reporter could measure lipids on single-organelle level. We 
generated hyperspectral maps to quantify the intracellular heterogeneity of lipid content within 
individual endolysosomal organelles of single bone marrow derived monocytes during the 
differentiation process into bone marrow derived macrophages (BMDM) (Figure 8a). 
Hyperspectral images of two cells (Figure 8b) from the bone marrow-derived monocyte 
population on day 3 of differentiation showed distinctly different intracellular heterogeneity of 
the reporter response, evident from the histogram widths (Figures 8c, S35). To mathematically 
quantify the intracellular heterogeneity of reporter emission within each cell, we used the 
normalized Simpson’s Index (nSI), a statistical measure of diversity.61,62 For the cells shown in 
Figure 8c, the nSIs were significantly different (Cell 1 nSI = 0.18, Cell 2 nSI = 0.74). By plotting 
the mean reporter emission wavelength and nSI for a large population of cells on day 3, cells 
with the most lipid-rich endolysosomal organelles (shorter wavelength) exhibited greater 
intracellular heterogeneity in endolysosomal lipid contents (Figure 8d, Spearman correlation of 
0.33, p < 0.01, for n = 64 cells). This observation, confirmed in BMDMs isolated from 4 
different mice (Figure S36, with at least 60 cells analyzed per mouse), suggests that within 
differentiating monocytes, cells with lipid-rich endolysosomal organelles maintain a sub-
population of these organelles that are relatively lipid-deficient. Moreover, observation of 
BMDMs throughout differentiation validated the ability of the reporter to detect endolysosomal 
lipid accumulation in a non-pathological condition (Figure S37-38). 
 Figure 8. Quantifying intracellular heterogeneity in monocyte endolysosomal organelles. (a) Near-infrared 
broadband and overlaid brightfield/hyperspectral images of the reporter in bone marrow-derived cells after 3 days of 
colony stimulating factor-1 (CSF-1) treatment. (b) Endolysosomal lipid maps of the reporter in bone marrow-
derived cells at day 3 of maturation. (c) Corresponding histogram of reporter emission from emissive pixels within 
the two cells. Bin size = 1 nm. (d) Scatterplot of the normalized Simpson’s Index (nSI) against the mean emission 
wavelength per cell for n = 64 cells. Scale bars = 10 µm 
 
CONCLUSION 
In this work, we developed a carbon nanotube optical reporter, composed of the (8,6) 
SWCNT species non-covalently functionalized with a short DNA oligonucleotide, that can 
function as an optical reporter of lipid content within the endolysosomal lumen of live cells. The 
near-infrared photoluminescence of the nanotube responds quantitatively to lipids in the local 
environment of the reporter via shifting of the nanotube optical bandgap. Experimental evidence 
and all-atom molecular dynamics simulations suggest that the mechanism of the response is 
solvatochromic shifting due to the reduction in water density on the nanotube surface. The 
reporter remains within the endocytic pathway and localizes to the lumen of endolysosomal 
organelles without adversely affecting organelle morphology, structural integrity, or function.  In 
the endolysosomal lumen, the reporter’s near-infrared emission responds rapidly and reversibly 
to lipid accumulation. Via NIR hyperspectral microscopy, the reporter can quantitatively map 
lipids in live cells. Using spectroscopy, the reporter can measure endolysosomal lipid 
accumulation in live cells in a high-throughput drug screening-type format. The reporter detected 
lipid accumulation in lysosomal storage disorders, including in the endolysosomal organelles of 
fibroblasts derived from a patient with Niemann-Pick type C, as well as phenotypic reversal in 
the same cells after drug treatment. The reporter functioned with single-cell and single-organelle 
resolution and was used to assess single-cell kinetics of modified LDL accumulation within 
endolysosomal organelles, showing that the rate of cholesterol accumulation differs by an order 
of magnitude across macrophages in the same population of cells. Endolysosomal lipid 
accumulation in differentiating bone marrow-derived monocytes was also observed, and high 
resolution endolysosomal lipid maps revealed intracellular heterogeneity in the form of a sub-
population of lipid-deficient endolysosomal organelles in lipid-rich cells. As the first technique 
for measuring lipid flux in the endolysosomal lumen of live cells, we expect this tool will have 
broad utility in both drug screening applications and in the investigation of disease pathways 
associated with altered lipid biology such as atherosclerosis, neurodegenerative diseases, 
lysosomal storage disorders, and liver disease.   
 
 
MATERIALS AND METHODS 
DNA encapsulation of single-walled carbon nanotubes  
The chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO, US) and Fisher 
Scientific (Pittsburgh, US). Single-walled carbon nanotubes (SWCNTs) produced by the HiPco 
process were used throughout the study (Unidym, Sunnyvale, CA). The carbon nanotubes were 
dispersed with DNA oligonucleotides via probe-tip ultrasonication (Sonics & Materials, Inc.) of 
2 mg of the specified oligonucleotide (IDT DNA, Coralville, IA) with 1 mg of raw SWCNT in 1 
mL of 0.1 M NaCl for 30 minutes at 40% of the maximum amplitude of the ultrasonicator 
(SONICS Vibra Cell).  Following ultrasonication, the dispersions were ultracentrifuged (Sorvall 
Discovery 90SE) for 30 minutes at 280,000 x g.  The top ¾ of the resultant supernatant was 
collected and its concentration was determined with a UV/Vis/NIR spectrophotometer (Jasco, 
Tokyo, Japan) using the extinction coefficient Abs910 = 0.02554 L mg
-1cm-1 19.  To remove free 
DNA, 100 kDa Amicon centrifuge filters (Millipore) were used to concentrate and re-suspend 
the DNA-nanotube complexes.   
 
Purification of single-chirality nanotube complexes 
Carbon nanotubes were separated by an ion-exchange chromatography (IEX) method according 
to the procedure described by Tu et al.32 Briefly, unsorted HiPco nanotubes were dispersed using 
a DNA oligonucleotide with the sequence ss(GT)6, as described above. The sample was injected 
into a high performance liquid chromatograph (HPLC) (Agilent, 1260 Infinity) fitted with an 
anion-exchange column (Biochrom Labs, Inc., CNT-NS1500) with a running buffer of 2x SSC at 
a flow rate of 2 mL/min. A linearly increasing salt concentration gradient of 1M NaSCN 
(5%/min) was used to elute the nanotubes from the stationary phase and fractions were collected. 
The first fraction exciting the HPLC contained the highest purity of the (8,6) species, estimated 
at 86%, which was used for subsequent studies. 
 
Near-infrared fluorescence microscopy of single-walled carbon nanotubes 
As described in a previous study,19 near infrared fluorescence microscopy was used to acquire 
the photoluminescence emission from SWCNTs. The system comprised a continuous wave 
(CW) 730 nm diode laser with an output power of 2 W injected into a multimode fiber to 
produce the excitation source for fluorescence experiments. To ensure a homogenous 
illumination over the entire microscope field of view, the excitation beam passed through a 
custom beam-shaping module to produce a top-hat intensity profile with under 20% power 
variation on the imaged region of the sample. The final power at the sample was 230 mW. A 
long pass dichroic mirror with a cut-on wavelength of 875 nm (Semrock) was aligned to reflect 
the laser to the sample stage of an Olympus IX-71 inverted microscope (with internal optics 
modified to improve near-infrared transmission from 900-1400 nm) equipped with a 20X 
LCPlan N, 20X/0.45 IR objective and a UAPON100XOTIRF, 1.49 oil objective (Olympus, 
USA). Emission was collected with a 2D InGaAs array detector (Photon Etc.). Z-stacks of 
broadband, widefield emission (from 900 to 1650 nm) were acquired in steps of 0.5 µm, which 
satisfied the Nyquist sampling criterion for 100X magnification. Custom codes, written using 
Matlab software, were used to subtract background, correct for non-uniformities in excitation 
profile, and compensate for dead pixels on the detector. Hyperspectral microscopy was 
conducted  by passing the emission through a volume Bragg grating (VBG) placed immediately 
before the InGaAs array in the optical path. The filtered image produced on the InGaAs camera 
was composed of a series of vertical lines, each with a specific wavelength. The reconstruction 
of a spatially-rectified image stack was performed using cubic interpolation on every pixel for 
each monochromatic image, according to the wavelength calibration parameters. The 
rectification produced a hyperspectral “cube” of images of the same spatial region exhibiting 
distinct spectral regions with 3.7 nm FHWM bandwidths. Approximately 50% of the emission 
intensity from the nanotubes is reduced after passage through the VBG. 
 
Analysis and processing of hyperspectral data 
Hyperspectral data acquired was saved as a (320 x 256 x 26) 16-bit array, where the first two 
coordinates signify the spatial location of a pixel and the last coordinate is its position in 
wavelength space. For the (8,6) nanotube, the 26-frame wavelength space ranges from 1150 nm 
to 1250 nm. An initial filter removed any pixels with a maximum intensity value outside (1170 
to 1220 nm), as these were background pixels that emit outside the range for (8,6). For the 
remaining pixels, a peak-finding algorithm was used to calculate the intensity range for a given 
pixel i.e. range = (intensity_maximum – intensity_minimum). A data point was designated as a 
peak if its intensity was range/4 greater than the intensity of adjacent pixels. Pixels that failed the 
peak-finding threshold, primarily due to low intensity above the background, were removed from 
the data sets. The remaining pixels were fit with a Lorentzian function.  
 
Preparation of nanotubes labeled with visible fluorophores 
To increase the fluorescence intensity of the Cy3 or Cy5 fluorophores attached to DNA strands 
encapsulating SWCNTs, a 6 nucleotide long polyT tail was added to the end of the (GT)6 
sequence, as fluorophores near the surface of SWCNTs are known to quench63 (Integrated DNA 
Technologies, sequence = GTGTGTGTGTGTTTTTTT). For confocal imaging with Alexa-647 
SWCNT, a small polyethylene glycol spacer was also added to further increase the fluorescence 
intensity of the fluorophore (Integrated DNA Technologies, sequence = 
GTGTGTGTGTGTTTTTTT/iSP18//3Alexaf647N//3’). These modified DNA-strands were non-
covalently complexed with HiPco SWCNTs via the previously described sonication and 
centrifugation protocol.  
 
Preparation of gold nanoparticle-conjugated nanotubes 
Gold nanoparticle-conjugated nanotubes were prepared according to a previously published 
study. Briefly, 10 nm citrate-capped gold nanoparticles were synthesized by bringing 50 mL of 
0.01 wt% HAuCl4 and adding 2 mL of 1 wt% Sodium(III) citrate. After 2 minutes, the solution 
turns bright red, indicating nanoparticle formation.  The gold nanoparticles were stabilized via a 
ligand exchange reaction by shaking overnight with bis(p-sulfonatophenyl)phenyl phosphine 
dihydrate dipotassium salt. The nanoparticles were then centrifuged and resuspended in 
deionized water. In parallel, ss(GT)27-T6-thiol-dispersed HiPco nanotube complexes were 
created by means of the previously described sonication and centrifugation protocol. The 
nanotube complexes were filtered with ultracentrifuge filters three times to remove unbound 
DNA. The nanotube complexes and excess gold nanoparticles were then shaken overnight. The 
unbound gold nanoparticles were removed via centrifugation, which would pellet the unbound 
nanoparticles, and careful supernatant extraction.  
 
Transmission electron microscopy (TEM) imaging 
Gold nanoparticle-nanotube conjugates were first imaged on carbon coated TEM grids by letting 
a 20 µL drop evaporate in the center of the grid. For imaging in RAW 264.7 cells, gold 
nanoparticle-nanotubes were introduced to the media for 30 minutes at 1 mg/L, and then washed 
thoroughly and replaced with fresh media. After 6 hours, cells were washed with serum-free 
media then fixed with a modified Karmovsky's fix of 2.5% glutaraldehyde, 4% 
paraformaldehyde and 0.02% picric acid in 0.1M sodium cacodylate buffer at pH 7.2.  Following 
a secondary fixation in 1% osmium tetroxide and 1.5% potassium ferricyanide, samples were 
dehydrated through a graded ethanol series, and embedded in an epon analog resin.  Ultrathin 
sections were cut using a Diatome diamond knife (Diatome, USA, Hatfield, PA) on a Leica 
Ultracut S ultramicrotome (Leica, Vienna, Austria).  Sections were collected on copper grids and 
further contrasted with lead citrate and viewed on a JEM 1400 electron microscope (JEOL, USA, 
Inc., Peabody, MA) operated at 120 kV.  Images were recorded with a Veleta 2K x2K digital 
camera (Olympus-SIS, Germany). 
 
Fluorescence microscopy of live cells 
Standard fluorescence imaging in the UV-visible emission range was performed on the 
hyperspectral microscope by using an XCite Series 120Q lamp as the light source and a QiClick 
CCD camera (QImaging) directly attached to a c-mount on a separate port of the microscope. 
Fluorescence filter sets from Chroma Technology and Semrock were used. Confocal imaging 
was performed on a Zeiss LSM 880, AxioObserver microscope equipped with a Plan-
Apochromat 63× Oil 1.4 NA differential interference contrast (DIC) M27 objective in a 
humidified chamber at 37 °C. Z-stacks were obtained using a step size of 198-220 nm. 
 
 
 
Fluorescence spectroscopy of carbon nanotubes in solution 
Fluorescence emission spectra from aqueous solutions of SWCNTs were acquired using a home-
built apparatus consisting of a tunable white light laser source, inverted microscope, and InGaAs 
NIR detector.54 The SuperK EXTREME supercontinuum white light laser source (NKT 
Photonics) was used with a VARIA variable bandpass filter accessory capable of tuning the 
output 500 – 825 nm with a bandwidth of 20 nm.  During the course of the measurements, the 
excitation wavelength remained at 730 nm, close to the resonant excitation maximum of the 
DNA-encapsulated (8,6) nanotube species. The light path was shaped and fed into the back of an 
inverted IX-71 microscope (Olympus) where it passed through a 20x NIR objective (Olympus) 
and illuminated a 100 µL nanotube sample at a concentration of 0.2 mg/L in a 96-well plate 
(Corning).  With an exposure time of 1 second, the emission from the nanotube sample was 
collected through the 20x objective and passed through a dichroic mirror (875 nm cutoff, 
Semrock). The light was f/# matched to the spectrometer using several lenses and injected into 
an Isoplane spectrograph (Princeton Instruments) with a slit width of 410 µm which dispersed 
the emission using a 86 g/mm grating with 950 nm blaze wavelength.  The spectral range was 
930 – 1369 nm with a resolution of ~0.7 nm. The light was collected by a PIoNIR InGaAs 640 x 
512 pixel array (Princeton Instruments).  A HL-3-CAL-EXT halogen calibration light source 
(Ocean Optics) was used to correct for wavelength-dependent features in the emission intensity 
arising from the spectrometer, detector, and other optics.  A Hg/Ne pencil style calibration lamp 
(Newport) was used to calibrate the spectrometer wavelength. Background subtraction was 
conducted using a well in a 96-well plate filled with DI H2O.  Following acquisition, the data 
was processed with custom code written in Matlab which applied the aforementioned spectral 
corrections, background subtraction, and was used to fit the data with Lorentzian functions. 
Nanotube chirality and DNA sequence-dependent response to LDL 
Unsorted DNA-SWCNT samples were diluted to 2 mg/L in PBS and incubated with 0.5 mg/mL 
LDL (Alfa Aesar) for 18 hours at 37 °C. Chirality-separated samples were diluted to mg/L in 
PBS and incubated with 0.5 mg/mL LDL for 18 hours at 37 °C. Controls were incubated with no 
LDL present. Photoluminescence spectra were acquired with 2-second exposure times. 
 
Titrations of DNA-nanotube complexes with PEG-conjugated lipids 
Unsorted ss(GT)6-DNA-SWCNT samples were diluted to mg/L in PBS and incubated with 
various concentrations (0-5M) of two polyethylene glycol (PEG)-conjugated lipids 
(Cholesterol-PEG 600, “Cholesterol-PEG”, Sigma Aldrich; C16 PEG750 Ceramide, Avanti 
Lipids). Samples were incubated for 2 hours at 37 °C. Photoluminescence spectra were acquired 
with 2-second exposure times under 730 nm laser excitation. Polyethylene glycol, with 
molecular weights of 600 or 750 kDa, diluted in PBS, were used as controls to test for non-
specific interactions. To test the effect of lowered pH on sensor performance, samples were 
diluted in a 100 mM pH 5.5 acetate buffer instead of PBS.  
 
Calculation of normalized Simpson’s Index 
The Simpson’s index is a diversity index used to measure the richness and evenness of a basic 
data type.62 The diversity index is maximized when all types of data are equally abundant.  When 
applied to microbiology, the Simpson’s Index is referred to as the Hunter-Gaston index.62 In our 
application,  
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where D is the diversity index, N is the total number of pixels within each cell with detectable 
nanotube emission, S is the total number of histogram bins, and nj is the total number of pixels 
within the jth bin. We obtained the Simpson’s Index for each cell, SIj. For the set of SIj calculated 
for all the cells in an experiment, we normalized the value obtain the normalized Simpson’s 
Index, nSI. 
 
Cell culture reagents and conditions 
RAW 264.7 TIB-71 cells (ATCC, Manassas, VA) were grown under standard incubation 
conditions at 37˚C and 5% CO2 in sterile, filtered DMEM with 10% heat-inactivated FBS, 2.5% 
HEPES, 1% glutamine, and 1% penicillin/streptomycin (all from Gibco).  For studies performed 
with homozygous mutant NPC, compound mutant heterozygote NPC, or wild-type fibroblasts, 
the respective cell lines, GM18453, GM03123 or GM05659 (Coriell, Camden, NJ) were cultured 
in MEM with 10% FBS, 2.5% HEPES, and 1% glutamine.  Cells were plated on glass bottom 
petri dishes or lysine-covered glass dishes (MatTek) for fibroblasts. U2OS-SRA cells Chirality-
separated SWCNTs were added at 0.2 mg/L in cell culture media (70 µL total volume) and 
incubated with cells for 30 minutes at 37 °C. This corresponds to approximately 0.5 picogram of 
SWCNT per cell, for a 50% cell confluency in a 9 mm diameter glass-bottom dish. The same 
procedure was used for unsorted SWCNTs with a concentration of 1 mg/L. These concentrations 
were chosen because they were experimentally observed to be the minimum concentration 
needed to obtain strong reporter signal from all of the cell lines used in the manuscript. An 
incubation time of 30 minutes was chosen because it was the minimal duration that resulted in a 
strong reporter signal from all the cell lines used in the manuscript.  
  Cells were imaged immediately, or trypsinized (Gibco), and re-plated on a fresh petri dishes 
before hyperspectral imaging. All cells were used at 50-70% confluence. 
 
Filipin staining of NPC1 patient-derived fibroblasts 
Cells were fixed with 4% paraformaldehyde for 15 minutes, washed 3x with PBS, and stained 
with Filipin III (Sigma) at a concentration of 50 µg/mL for 20 minutes. The cells were then 
washed 3x with PBS and imaged using a DAPI filter cube. 
 
Cell viability and proliferation assays 
RAW 264.7 macrophages were seeded in untreated 96-well plates at 7,000 cells per well. The 
reporter was introduced to the cells at 0.2 mg/L. Reporter, vehicle (0.027 MSSC + 0.1 M 
NaSCN), or hydrogen peroxide-treated cells were incubated (times indicated), washed, and 
detached from the plate with Versene (1x PBS without Mg2+/Ca2+, 5mM EDTA, 2% FBS), 
pelleted, and incubated with Annexin V Alexa Fluor and Propidium Iodide (Life Technologies). 
Cells were analyzed by imaging cytometry (Tali) to quantify cell number and fluorophore 
content. For proliferation assays, RAW 264.7 macrophages treated with 0.2 mg/L ss(GT)6-(8,6)-
SWCNT or vehicle were seeded at 150,000 cells on 100 mm diameter untreated culture dish on 
day zero. After settling for 10 hours, cells were harvested with Versene (1x PBS without 
Mg2+/Ca2+, 5mM EDTA, 2% FBS) and by mechanical tapping to remove cells from the surface, 
stained with Calcein AM, and counted for the initial seeding density. Media was replaced every 
2 days. At each 24 hour period, cells were harvested as before and counted. Cell counts represent 
Calcein AM positive (live) cells. 
 
Lipidomics analyses 
Six T-175 flasks were seeded at <50% confluence with RAW 264.7 macrophages in their fifth 
passage. Three flasks each were treated as follows: control (untreated) or carbon nanotube 
treated (0.2 mg/L for 30 minutes, washing, and incubating for 6 hours). Cells were harvested 
(approx. 80% confluence in each set of flasks) by manual scraping. The flask contents 
corresponding to each condition were pooled into separate conical tubes and spun to pellet, 
washed in PBS containing protease inhibitor cocktail (Thermo-Pierce, 88666), pelleted, and flash 
frozen in a dry ice/IPA slurry with a small head volume of the PBS/inhibitor. 
 For cell fractionation we adapted a sucrose/iodixanol equilibrium gradient centrifugation 
procedure for lysosome separation (Thermo, 89839). Briefly, flash frozen cells were thawed and 
suspended in 2x cpv of PBS/inhibitor, vortexed with reagent included in the kit, and Dounce 
homogenized with a cooled, tight fitting pestle using 90 strokes (starting cell material was >500 
mg). After homogenization, reagent was added, tube inverted, and then centrifuged at 4˚C, 500x 
rcf for 10 minutes. The pellet was stored as the debris/nuclear fraction in all experiments. The 
supernatant was taken for subsequent ultracentrifugation. Briefly, one day before 
ultracentrifugation, a sucrose/iodixanol gradient (bottom to top: 30, 27, 23, 20, 17%) was layered 
into 12 mL polyallomer tubes (Thermo, 03699) and allowed to equilibrate in a cold room inside 
the metal buckets of an appropriate hanging-bucket rotor. The supernatant from above was 
mixed with the sucrose/iodixanol gradient to make a final sample density of 15% (total volume, 
1 mL), which was then gently layered onto the top of the pre-formed gradient. The buckets were 
then sealed and moved into the ultracentrifuge using the following settings: ~135,000 rcf (32,000 
rpm), 2.5 hours running time, acceleration/deceleration 9/5, 4˚C. The fractionated cell 
supernatant was removed from the top, and pipetted into six fractions based on volume removed 
from the ultracentrifuge tube. The volume removed from top to bottom was kept constant across 
the three conditions. Fractions were frozen until analysis. 
 Each of the six fractions, plus the nuclear/debris fraction (7 total/condition) was analyzed 
for the three conditions (21 fractions total). To quantify total protein, a standard curve was 
produced using BSA mixed into the sucrose/iodixanol gradient (Bradford assay background 
versus varying gradient was not different). 1x Bradford reagent at room temperature was mixed 
1:1 with standard, allowed to incubate in the dark for 30 minutes, and the absorption measured at 
595 nm. Each of the fractions was analyzed in this manner after addition of 0.2% IPEGAL CA-
630 (non-ionic detergent) to solubilize bound proteins.  
 Cholesterol quantification was performed (Sigma, MAK043) using a coupled enzyme 
reaction between cholesterol oxidase and peroxidase with a proprietary colorimetric probe. 
Cholesterol esterase was used before the reactions to ensure total cholesterol was measured. 
Briefly, a 3-phase extraction was performed on each sample fraction (7:11:0.1 
chloroform:isopropanol:IPEGAL CA-630). The top aqueous phase and interphase were 
removed, and the bottom organic phase was vacuum dried. The dried fractions were resuspended 
in provided buffer and reacted for 1 hour at 37˚C with the supplied reagents and the absorption 
read at 570 nm. This was compared to a standard curve. Cholesterol levels were normalized by 
total protein content as measured by the Bradford assay. 
 Total lipid (total unsaturated hydrocarbon, including cholesterol) was measured after 
chloroform extracting the samples as above. Briefly, a phospho-vanillin color producing reagent 
was made by dissolving 5 mg/mL vanillin (Sigma, V1104) in 200 μL neat ethanol, and adding 
this to the appropriate volume of 17% phosphoric acid. This reagent was stored cool in the dark 
until needed. Dried sample fractions in glass vials were processed as follows: to each vial was 
added 200 μL ~98% sulfuric acid. The dried contents were coated with the acid by tipping the 
vial and vortexing. The vial was placed into a 100˚C mineral oil bath for 20 minutes. The 
resulting brown/black material was rapidly cooled in wet ice slurry for at least 5 minutes, and 
100 μL was placed side-by-side into a 96-well glass plate. To one well, 50 μL of the phospho-
vanillin reagent was added, mixed, and the plate incubated in the dark for 12 minutes. 
Absorption of each well (reagent reacted and sulfuric acid background) was taken at 535 nm. 
The difference was the measurement, which was compared to a standard curve that used Oleic 
acid (Sigma, O1008), prepared using the above protocol, as a model unsaturated hydrocarbon 
material. Total lipid levels were normalized by total protein content. 
 
Extraction and differentiation of bone marrow-derived macrophages  
Bone marrow derived cells (BMDM) were prepared from 6 week-old C57/Bl6 mice and cultured 
in the presence of 10 ng/ml of recombinant colony stimulating factor-1 (CSF-1).64 Cells were 
collected 3, 5 and 7 days post-isolation and submitted to flow cytometry analysis for expression 
of the differentiation markers Gr-1 (monocytes/granulocytes-1/200), Cd11b (macrophages-
1/200), F4/80 (mature macrophages-1/50). Cells were incubated with 1 µl of Fc Block (BD 
Biosciences) for every million cells for at least 15 minutes at 4°C. Cells were then stained with 
the appropriate antibodies (BD Biosciences) for 20 minutes at 4°C, washed with FACS buffer, 
and resuspended in FACS buffer containing DAPI (5 mg/ml diluted 1:5,000) for live/dead cell 
exclusion.65  
 
 
 
LysoTracker-nanotube colocalization 
RAW 264.7 or BMDM macrophages were incubated with Cy5-ss(GT)6-HiPco nanotubes for 30 
minutes at a concentration 1 mg/L. The cells were then washed 3x with PBS and placed in fresh 
cell media. Six hours later, the cells were incubated with 5 nM LysoTracker Green DND-26 
(Life Technologies) for 15 minutes in cell media, washed 3x with PBS, and imaged immediately 
in fresh PBS. The FITC or Cy5 channels were used for LysoTracker Green or Cy5-ss(GT)6-
HiPco nanotubes, respectively. Plates of cells containing only Cy5-ss(GT)6-HiPco nanotubes or 
LysoTracker Green were used as controls to test for bleed-through across channels.   
 
Atomic force microscopy (AFM) 
A stock solution of ss(GT)6-(8,6)-SWCNTs at 7 mg/L in 100 mM NaCl was diluted 20x in dH2O 
and plated on a freshly cleaved mica substrate (SPI) for 4 minutes before washing with 10 mL of 
dH2O and blowing dry with argon gas.  An Olympus AC240TS AFM probe (Asylum Research) 
in an Asylum Research MFP-3D-Bio instrument was used to image in AC mode. Data was 
captured at 2.93 nm/pixel XY resolution and 15.63 pm Z resolution. 
 
Statistics 
Statistical analysis was performed with GraphPad Prism version 6.02. All data met the 
assumptions of the statistical tests performed (i.e. normality, equal variances, etc.). Experimental 
variance was found to be similar between groups using the F-test and Brown-Forsythe test for 
unpaired t-tests and one way ANOVAs, respectively. To account for the testing of multiple 
hypotheses, one way ANOVAs were performed with Dunnet’s, Tukey’s, or Sidak’s post tests 
when appropriate. Sample size decisions were based on the instrumental signal-to-noise ratios. 
Cell line source and authentication 
RAW 264.7 and U2OS cells were acquired from ATCC, and were tested for mycoplasma 
contamination by the source. Primary bone-marrow derived monocytes were tested for 
mycoplasma contamination using Dapi staining. Patient-derived fibroblasts were obtained from 
Coriell and tested for mycoplasma contamination by the source. 
 
Code availability 
Matlab code for the data analysis in this manuscript is available upon request, by contacting the 
corresponding author (hellerd@mskcc.org). 
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